Näytä suppeat kuvailutiedot

dc.contributor.authorKunutsor, Setor K.
dc.contributor.authorMäkikallio, Timo H.
dc.contributor.authorKauhanen, Jussi
dc.contributor.authorVoutilainen, Ari
dc.contributor.authorJae, Sae Young
dc.contributor.authorDey, Richard S.
dc.contributor.authorKurl, Sudhir
dc.contributor.authorLaukkanen, Jari
dc.date.accessioned2019-09-17T07:05:55Z
dc.date.available2019-09-17T07:05:55Z
dc.date.issued2020
dc.identifier.citationKunutsor, S. K., Mäkikallio, T. H., Kauhanen, J., Voutilainen, A., Jae, S. Y., Dey, R. S., Kurl, S., & Laukkanen, J. (2020). Leisure‐time cross‐country skiing is associated with lower incidence of type 2 diabetes : A prospective cohort study. <i>Diabetes/Metabolism Research and Reviews</i>, <i>36</i>(1), Article e3216. <a href="https://doi.org/10.1002/dmrr.3216" target="_blank">https://doi.org/10.1002/dmrr.3216</a>
dc.identifier.otherCONVID_32838656
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/65529
dc.description.abstractAims. Cross‐country skiing is associated with reduction in risk of adverse vascular outcomes, but its association with type 2 diabetes is uncertain. We aimed to assess the associations between leisure‐time cross‐country skiing habits and incident type 2 diabetes. Methods. We analyzed data of 2,483 middle‐aged men with no history of diabetes at baseline in the KIHD prospective study. The frequency, average duration, and intensity of leisure cross‐country skiing were assessed at baseline using a 12‐month physical activity questionnaire. Hazard ratios (HRs) (95% CIs) for type 2 diabetes were estimated. Results. During a median follow‐up of 21.6 years, 539 men developed type 2 diabetes. Type 2 diabetes risk decreased with increasing total volume of cross‐country skiing up to 1,215 MET hours/year. In analyses adjusted for several established risk factors, when compared to men with no cross‐country skiing activity, the HRs (95% CIs) for type 2 diabetes were 0.75 (0.62‐0.92) and 0.59 (0.46‐0.76) for men who did 1‐200 and >200 MET hours/year of cross‐country skiing respectively. Compared to men with no cross‐country skiing activity, the corresponding adjusted HRs (95% CIs) for type 2 diabetes were 0.73 (0.60‐0.89) and 0.64 (0.50‐0.82) for men who did 1‐60 and >60 mins/week of cross‐country skiing respectively. The associations remained consistent following further adjustment for prevalent comorbidities. Conclusion. Total volume and duration of leisure‐time cross‐country skiing are each inversely and independently associated with future type 2 diabetes risk in a male population. Cross‐country skiing undertaken as a leisure activity has the potential to promote public health.en
dc.format.mimetypeapplication/pdf
dc.languageeng
dc.language.isoeng
dc.publisherJohn Wiley & Sons
dc.relation.ispartofseriesDiabetes/Metabolism Research and Reviews
dc.rightsIn Copyright
dc.subject.otherphysical activity
dc.subject.othercross-country skiing
dc.subject.otherhigh-intensity exercise training
dc.subject.othertype 2 diabetes
dc.titleLeisure‐time cross‐country skiing is associated with lower incidence of type 2 diabetes : A prospective cohort study
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-201909174174
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1520-7552
dc.relation.numberinseries1
dc.relation.volume36
dc.type.versionacceptedVersion
dc.rights.copyright© John Wiley & Sons Ltd, 2019
dc.rights.accesslevelopenAccessfi
dc.subject.ysohiihto
dc.subject.ysoharjoittelu
dc.subject.ysofyysinen aktiivisuus
dc.subject.ysoaikuistyypin diabetes
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p11094
jyx.subject.urihttp://www.yso.fi/onto/yso/p26412
jyx.subject.urihttp://www.yso.fi/onto/yso/p23102
jyx.subject.urihttp://www.yso.fi/onto/yso/p8303
dc.rights.urlhttp://rightsstatements.org/page/InC/1.0/?language=en
dc.relation.doi10.1002/dmrr.3216
jyx.fundinginformationThe authors acknowledge the Finnish Foundation for Cardiovascular Research, Helsinki, Finland, for supporting the Kuopio Ischemic Heart Disease Study. THM and SKK acknowledge support from the Division of Cardiology, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland via the Finnish Governmental Research Funding (VTR). SKK acknowledges support from the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.These sources had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

In Copyright
Ellei muuten mainita, aineiston lisenssi on In Copyright